Acute Lymphoblastic Leukemia in Adults

Our pathologists, hematologists, and oncologists combine their expertise to determine the genetic characteristics of acute lymphoblastic leukemia, a fast-growing cancer of the blood and bone marrow. Together, we accurately diagnose the condition and create a personalized treatment plan, which may include chemotherapy, targeted medications, or stem cell transplantation. Throughout the treatment process and beyond, we provide supportive services to you and your loved ones.

Clinical Trials and Research Studies

Phase 1/2

Relapsed or Refractory Acute Myeloid Leukemia: Venetoclax and Alvocidib

Learn More

Phase 1

A Phase 1a/1b Dose Escalation and Expansion Trial of TTI-621 a Novel Biologic Targeting CD47 in Subjects with Relapsed or Refractory Hematologic Malignancies and Selected Solid Tumors

Learn More

Phase 1/2

AN OPEN-LABEL MULTICENTER PHASE l/1B TRIAL EVALUATING THE SAFETY ANDPHARMACOKINETICS OF ESCALATING DOSES OF BTCT4465A AS A SINGLE AGENT ANDCOMBINED WITH ATEZOLIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORYB-CELL NON-HODGKIN S LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA

Learn More

Phase 2

AALL1621: A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518 IND#133494) in Children and Young Adults with Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)

Learn More